The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The lys-1 gene (ORF Y22F5A.4) in Caenorhabditis elegans encodes Lysozyme-Like Protein 1 (LYS-1), a member of the glycosyl hydrolase family 25 (GH25). The C. elegans genome encodes 10 protist-type lysozymes (lys-1 through lys-10), all belonging to the GH25 family, as well as six invertebrate-type lysozymes (ilys-1 through ilys-6) (simonsen2012strengthinnumbers pages 4-5, schulenburg2004evolutionofthe pages 7-8). The protist-type lysozymes in C. elegans are structurally most similar to lysozymes found in the amoeboid protozoon Entamoeba histolytica, rather than to the chicken-type (GH22) or insect-type lysozyme families that are well-characterized in vertebrates and arthropods (schulenburg2004evolutionofthe pages 7-8, mallo2002inducibleantibacterialdefense pages 2-3). This phylogenetic relationship suggests an ancient protist-type lysozyme lineage retained in nematodes.
LYS-1 is classified as a muramidase (EC 3.2.1.17) based on its membership in the GH25 family. GH25 muramidases catalyze the hydrolysis of the β-1,4-glycosidic bond between N-acetylmuramic acid (MurNAc/NAM) and N-acetylglucosamine (GlcNAc/NAG) in the carbohydrate backbone of bacterial peptidoglycan (moroz2021fungalgh25muramidases pages 1-2). Characterized GH25 enzymes exhibit both β-1,4-N-acetyl- and β-1,4-N,6-O-diacetylmuramidase activities (moroz2021fungalgh25muramidases pages 1-2). The catalytic mechanism of GH25 muramidases involves substrate-assisted catalysis: an aspartate residue acts as a general acid, donating a proton to the glycosidic oxygen, while the N-acetyl group of the substrate itself acts as the enzymatic nucleophile to stabilize the oxocarbenium ion-like transition state (moroz2021fungalgh25muramidases pages 13-16). This mechanism is shared with family GH20 chitobiases.
While no direct biochemical characterization of recombinant LYS-1 has been published, its enzymatic activity as a peptidoglycan-degrading muramidase is strongly inferred from its GH25 family membership and conserved domain architecture (simonsen2012strengthinnumbers pages 4-5, moroz2021fungalgh25muramidases pages 1-2). As antimicrobial proteins, lysozymes function by breaking down peptidoglycan, the major structural component of bacterial cell walls, causing bacterial cell lysis (simonsen2012strengthinnumbers pages 4-5). In E. histolytica, the related protist-type lysozymes are known to act synergistically with amoebapores to break up bacteria, and a similar synergistic action with C. elegans amoebapore-like peptides (SPP family) has been hypothesized (mallo2002inducibleantibacterialdefense pages 2-3).
LYS-1 is primarily expressed in intestinal cells throughout the length of the nematode body, consistent with its role as an antimicrobial effector at the primary site of pathogen encounter (mallo2002inducibleantibacterialdefense pages 3-4, alper2007specificityandcomplexity pages 3-4). Using lys-1::GFP reporter constructs, expression has been detected at multiple positions along the intestine, including mid-body, anterior-to-mid-body, and posterior regions (alper2007specificityandcomplexity pages 3-4). In addition to intestinal expression, lys-1::GFP is also expressed in specific neuronal populations, including the six IL1 and six IL2 neurons, a few additional neurons in the head ganglia, and two posterior phasmid chemosensory neurons (mallo2002inducibleantibacterialdefense pages 3-4, alper2007specificityandcomplexity pages 3-4, mallo2002inducibleantibacterialdefense pages 2-3). The functional significance of neuronal expression remains unclear.
At the subcellular level, LYS-1::GFP localizes to vesicles within intestinal cells. These vesicles are distinct from secondary lysosomes and show a high concentration at the apical surface of intestinal cells, suggesting trafficking toward the intestinal lumen (mallo2002inducibleantibacterialdefense pages 3-4, schulenburg2004evolutionofthe pages 7-8). This localization pattern is reminiscent of the granular exocytosis mechanisms described in E. histolytica and secretory lysosomes in cytotoxic T lymphocytes (schulenburg2004evolutionofthe pages 7-8). The apical/luminal secretion is consistent with LYS-1 acting directly on bacteria present in the intestinal lumen, the primary site where S. marcescens and other pathogens colonize (mallo2002inducibleantibacterialdefense pages 3-4).
The expression of lys-1 is regulated by multiple conserved innate immune signaling pathways:
TIR-1/NSY-1 (SARM-MAPKKK) pathway: RNAi-mediated knockdown of either nsy-1 (a MAPKKK) or tir-1 (a TIR domain adaptor protein upstream of NSY-1) leads to strong reduction of lys-1 expression, demonstrating that this pathway is a major positive regulator of constitutive lys-1 transcription (alper2007specificityandcomplexity pages 5-7, alper2007specificityandcomplexity pages 4-5). The effects of tir-1 and nsy-1 knockdown on lys-1 are nearly identical, consistent with their action in the same signaling cascade.
PMK-1/p38 MAPK pathway: Several studies have confirmed that lys-1 is a PMK-1-dependent immune gene. In studies of probiotic-mediated immune stimulation, upregulation of lys-1 by heat-inactivated Lactobacillus curvatus was abolished in pmk-1 mutants, demonstrating PMK-1 dependence (dinic2021probioticmediatedp38mapk pages 4-5). Additionally, the bZIP transcription factor ZIP-11, which acts in a feedback loop with the PMK-1/p38 pathway, was shown to regulate lys-1 among other PMK-1-dependent immune genes (zheng2021thebziptranscription pages 6-8).
TGF-β/DBL-1 pathway and PMK-1 dual regulation: One study explicitly noted that "the lysozyme-like protein Lys-1 is regulated by both TGF-β and PMK-1 signaling pathways" (liu2013componentsofthe pages 4-5, liu2013componentsofthe pages 2-2).
DAF-2/DAF-16 insulin-like signaling pathway: lys-1 has been identified as a putative target of the DAF-16/FOXO transcription factor. In a genetic screen for DAF-16 target genes, RNAi knockdown of lys-1 resulted in a synthetic dauer-constitutive (SynDaf) phenotype in a sensitized background, linking lys-1 to the insulin-like signaling network that regulates both immunity and dauer formation (jensen2010rnaiscreenof pages 2-3, jensen2010rnaiscreenof pages 4-5).
The transcriptional induction of lys-1 exhibits pathogen specificity. In the original study by Mallo et al. (2002), lys-1 was identified as one of the most robustly induced genes following infection with the Gram-negative bacterium Serratia marcescens, confirmed by both microarray and Northern blot analyses at 24 and 48 hours post-infection (mallo2002inducibleantibacterialdefense pages 2-3, mallo2002inducibleantibacterialdefense pages 1-2). Subsequent work by Alper et al. (2007) found that lys-1 was induced by Pseudomonas aeruginosa but not by S. marcescens in their experimental conditions, highlighting that quantitative differences in induction can depend on experimental context, timing, and bacterial strain (alper2007specificityandcomplexity pages 5-7). More recent studies have confirmed lys-1 upregulation in the context of Staphylococcus aureus infection (jensen2010rnaiscreenof pages 2-3) and various other pathogenic and probiotic bacterial challenges (dinic2021probioticmediatedp38mapk pages 4-5).
Overexpression: Transgenic C. elegans overexpressing the lys-1::GFP fusion construct showed significantly increased survival when challenged with the protease-deficient S. marcescens strain Db1140, providing direct evidence that LYS-1 contributes to antibacterial defense (mallo2002inducibleantibacterialdefense pages 1-2, mallo2002inducibleantibacterialdefense pages 3-4). Importantly, overexpression did not confer protection against the more virulent wild-type Db11 strain, likely because bacterial proteases produced by virulent S. marcescens can counteract LYS-1's protective effects (mallo2002inducibleantibacterialdefense pages 3-4, schulenburg2004evolutionofthe pages 6-7). Overexpression of lys-1 has also been noted to augment resistance to S. marcescens in other reports (mallo2002inducibleantibacterialdefense pages 1-2).
Knockdown: RNAi knockdown of lys-1 in wild-type worms had little effect on survival against S. marcescens, suggesting that multiple redundant defense factors contribute to antibacterial immunity in C. elegans (mallo2002inducibleantibacterialdefense pages 3-4, schulenburg2004evolutionofthe pages 6-7). However, in a sensitized RNAi-hypersensitive background (rrf-3), lys-1 RNAi significantly reduced survival upon S. aureus challenge, indicating that LYS-1 does contribute to pathogen resistance when other defense mechanisms are limiting (jensen2010rnaiscreenof pages 2-3, jensen2010rnaiscreenof pages 4-5).
An intriguing link has been established between lys-1-mediated innate immunity and the developmental decision to enter the dauer larval stage. Jensen et al. (2010) showed that lys-1 knockdown causes a synthetic dauer-constitutive phenotype when combined with the sdf-9 mutation, suggesting that infection-induced stress or compromised immunity can feed back into the dauer signaling circuit (jensen2010rnaiscreenof pages 2-3, jensen2010rnaiscreenof pages 4-5). This is consistent with the broader model that pathogen exposure increases dauer pheromone production and promotes dauer entry as a behavioral response to pathogenic environments (jensen2010rnaiscreenof pages 3-4).
The following table summarizes the key properties of LYS-1:
| Property | Summary | Evidence |
|---|---|---|
| Gene name | lys-1; encodes lysozyme-like protein 1 in Caenorhabditis elegans | (mallo2002inducibleantibacterialdefense pages 2-3, alper2007specificityandcomplexity pages 1-2) |
| ORF | Y22F5A.4 | (mallo2002inducibleantibacterialdefense pages 2-3) |
| UniProt ID | O62415 | (mallo2002inducibleantibacterialdefense pages 2-3) |
| Protein family | Protist-type lysozyme; glycosyl hydrolase family 25 (GH25), one of 10 C. elegans protist-type lysozymes (lys-1 to lys-10) | (simonsen2012strengthinnumbers pages 4-5, schulenburg2004evolutionofthe pages 7-8, mallo2002inducibleantibacterialdefense pages 2-3) |
| Enzymatic activity | Predicted muramidase/lysozyme that hydrolyzes bacterial peptidoglycan; direct biochemical activity has not been shown for LYS-1 itself, but inferred from GH25 family membership | (simonsen2012strengthinnumbers pages 4-5, moroz2021fungalgh25muramidases pages 1-2, moroz2021fungalgh25muramidases pages 13-16) |
| Substrate | Bacterial peptidoglycan, specifically the β-1,4 glycosidic bond between MurNAc/NAM and GlcNAc/NAG in the glycan backbone | (vollmer2008bacterialpeptidoglycan(murein) pages 6-7, moroz2021fungalgh25muramidases pages 1-2) |
| Catalytic mechanism | Inferred GH25 mechanism: substrate-assisted catalysis with an Asp acting as general acid; the substrate N-acetyl group contributes to catalysis | (moroz2021fungalgh25muramidases pages 13-16) |
| Tissue expression | Strongly expressed in intestinal cells; also reported in IL1/IL2 neurons, head ganglia neurons, and posterior phasmid chemosensory neurons in reporter analyses | (mallo2002inducibleantibacterialdefense pages 2-3, mallo2002inducibleantibacterialdefense pages 3-4, alper2007specificityandcomplexity pages 3-4) |
| Subcellular localization | Vesicular localization in intestinal cells, with vesicles concentrated near the apical surface; distinct from secondary lysosomes and suggestive of trafficking toward the intestinal lumen | (schulenburg2004evolutionofthe pages 7-8, mallo2002inducibleantibacterialdefense pages 3-4) |
| Likely site of action | Likely acts in or toward the intestinal lumen, consistent with defense against ingested bacteria and luminal pathogens | (schulenburg2004evolutionofthe pages 7-8, mallo2002inducibleantibacterialdefense pages 3-4) |
| Signaling pathways regulating expression | Expression requires TIR-1/NSY-1 innate immune signaling; lys-1 is also reported to be regulated by PMK-1/p38 MAPK and TGF-β/DBL-1 pathways; lys-1 is additionally described as a DAF-16/FOXO target in the insulin-like signaling network | (alper2007specificityandcomplexity pages 5-7, alper2007specificityandcomplexity pages 4-5, liu2013componentsofthe pages 4-5, jensen2010rnaiscreenof pages 2-3, dinic2021probioticmediatedp38mapk pages 4-5) |
| Pathogen induction | Reported as induced during infection by Serratia marcescens and Pseudomonas aeruginosa; one study found induction by P. aeruginosa but not S. marcescens, indicating pathogen- and condition-specific regulation across assays | (mallo2002inducibleantibacterialdefense pages 2-3, mallo2002inducibleantibacterialdefense pages 1-2, alper2007specificityandcomplexity pages 5-7) |
| Functional evidence: overexpression | Transgenic overexpression/lys-1::GFP animals showed increased resistance to the less virulent S. marcescens strain Db1140, but not to the more virulent strain Db11 | (mallo2002inducibleantibacterialdefense pages 1-2, mallo2002inducibleantibacterialdefense pages 3-4) |
| Functional evidence: knockdown | lys-1 RNAi abolished reporter expression but had little effect on survival against S. marcescens Db1140, suggesting redundancy; in a separate study, lys-1 RNAi increased sensitivity to Staphylococcus aureus and promoted dauer-related phenotypes in a sensitized background | (schulenburg2004evolutionofthe pages 6-7, jensen2010rnaiscreenof pages 2-3, jensen2010rnaiscreenof pages 4-5, mallo2002inducibleantibacterialdefense pages 3-4) |
| Biological role | Antibacterial innate immune effector positioned at host-environment interfaces, especially the intestine; likely contributes to bacterial cell-wall degradation and host defense in combination with other effectors | (schulenburg2004evolutionofthe pages 7-8, alper2007specificityandcomplexity pages 1-2, simonsen2012strengthinnumbers pages 4-5) |
| Evolutionary relationships | LYS-1 is evolutionarily closer to protist/Entamoeba histolytica lysozymes than to classical vertebrate chicken-type or insect lysozymes; this supports an ancient protist-type lysozyme lineage in nematodes | (mallo2002inducibleantibacterialdefense pages 2-3, schulenburg2004evolutionofthe pages 7-8) |
Table: This table summarizes the main annotated and experimentally supported properties of C. elegans LYS-1, including molecular identity, inferred enzymatic activity, localization, regulation, pathogen responsiveness, and functional evidence. It is useful as a compact evidence map for gene functional annotation.
In summary, C. elegans LYS-1 is a protist-type lysozyme of the glycosyl hydrolase family 25 that functions as an antimicrobial effector in the nematode's innate immune system. Based on its GH25 family membership, LYS-1 is predicted to catalyze the hydrolysis of the β-1,4-glycosidic bond between MurNAc and GlcNAc in bacterial peptidoglycan, using a substrate-assisted catalytic mechanism (moroz2021fungalgh25muramidases pages 1-2, moroz2021fungalgh25muramidases pages 13-16). The protein is expressed constitutively in intestinal cells, where it localizes to vesicles that traffic toward the apical surface for likely secretion into the intestinal lumen—the primary site of bacterial encounter (mallo2002inducibleantibacterialdefense pages 3-4, schulenburg2004evolutionofthe pages 7-8). Its expression is transcriptionally regulated by the TIR-1/NSY-1 SARM-MAPKKK pathway and the PMK-1/p38 MAPK cascade, as well as by the TGF-β/DBL-1 and DAF-2/DAF-16 insulin-like signaling pathways (alper2007specificityandcomplexity pages 5-7, alper2007specificityandcomplexity pages 4-5, liu2013componentsofthe pages 4-5, jensen2010rnaiscreenof pages 2-3, dinic2021probioticmediatedp38mapk pages 4-5). Functionally, overexpression of LYS-1 enhances resistance to bacterial pathogens, while its knockdown increases susceptibility, particularly to Staphylococcus aureus (mallo2002inducibleantibacterialdefense pages 1-2, jensen2010rnaiscreenof pages 2-3, mallo2002inducibleantibacterialdefense pages 3-4). The redundancy of the lysozyme family in C. elegans, with at least 16 lysozyme genes across two distinct families, likely reflects the central importance of peptidoglycan degradation in the nematode's bacterivorous lifestyle and innate immune defense (simonsen2012strengthinnumbers pages 4-5, schulenburg2004evolutionofthe pages 7-8).
References
(simonsen2012strengthinnumbers pages 4-5): Karina T. Simonsen, Sandra F. Gallego, Nils J. Færgeman, and Birgitte H. Kallipolitis. Strength in numbers. Virulence, 3:477-484, Oct 2012. URL: https://doi.org/10.4161/viru.21906, doi:10.4161/viru.21906. This article has 36 citations and is from a peer-reviewed journal.
(schulenburg2004evolutionofthe pages 7-8): Hinrich Schulenburg, C. Léopold Kurz, and Jonathan J. Ewbank. Evolution of the innate immune system: the worm perspective. Immunological Reviews, 198:36-58, Apr 2004. URL: https://doi.org/10.1111/j.0105-2896.2004.0125.x, doi:10.1111/j.0105-2896.2004.0125.x. This article has 317 citations and is from a domain leading peer-reviewed journal.
(mallo2002inducibleantibacterialdefense pages 2-3): Gustavo V. Mallo, C.Léopold Kurz, Carole Couillault, Nathalie Pujol, Samuel Granjeaud, Yuji Kohara, and Jonathan J. Ewbank. Inducible antibacterial defense system in c. elegans. Current Biology, 12:1209-1214, Jul 2002. URL: https://doi.org/10.1016/s0960-9822(02)00928-4, doi:10.1016/s0960-9822(02)00928-4. This article has 614 citations and is from a highest quality peer-reviewed journal.
(moroz2021fungalgh25muramidases pages 1-2): Olga V. Moroz, Elena Blagova, Edward Taylor, Johan P. Turkenburg, Lars K. Skov, Garry P. Gippert, Kirk M. Schnorr, Li Ming, Liu Ye, Mikkel Klausen, Marianne T. Cohn, Esben G. W. Schmidt, Søren Nymand-Grarup, Gideon J. Davies, and Keith S. Wilson. Fungal gh25 muramidases: new family members with applications in animal nutrition and a crystal structure at 0.78å resolution. PLOS ONE, 16:e0248190, Mar 2021. URL: https://doi.org/10.1371/journal.pone.0248190, doi:10.1371/journal.pone.0248190. This article has 12 citations and is from a peer-reviewed journal.
(moroz2021fungalgh25muramidases pages 13-16): Olga V. Moroz, Elena Blagova, Edward Taylor, Johan P. Turkenburg, Lars K. Skov, Garry P. Gippert, Kirk M. Schnorr, Li Ming, Liu Ye, Mikkel Klausen, Marianne T. Cohn, Esben G. W. Schmidt, Søren Nymand-Grarup, Gideon J. Davies, and Keith S. Wilson. Fungal gh25 muramidases: new family members with applications in animal nutrition and a crystal structure at 0.78å resolution. PLOS ONE, 16:e0248190, Mar 2021. URL: https://doi.org/10.1371/journal.pone.0248190, doi:10.1371/journal.pone.0248190. This article has 12 citations and is from a peer-reviewed journal.
(mallo2002inducibleantibacterialdefense pages 3-4): Gustavo V. Mallo, C.Léopold Kurz, Carole Couillault, Nathalie Pujol, Samuel Granjeaud, Yuji Kohara, and Jonathan J. Ewbank. Inducible antibacterial defense system in c. elegans. Current Biology, 12:1209-1214, Jul 2002. URL: https://doi.org/10.1016/s0960-9822(02)00928-4, doi:10.1016/s0960-9822(02)00928-4. This article has 614 citations and is from a highest quality peer-reviewed journal.
(alper2007specificityandcomplexity pages 3-4): Scott Alper, Sandra J. McBride, Brad Lackford, Jonathan H. Freedman, and David A. Schwartz. Specificity and complexity of the caenorhabditis elegans innate immune response. Aug 2007. URL: https://doi.org/10.1128/mcb.02070-06, doi:10.1128/mcb.02070-06. This article has 232 citations and is from a domain leading peer-reviewed journal.
(alper2007specificityandcomplexity pages 5-7): Scott Alper, Sandra J. McBride, Brad Lackford, Jonathan H. Freedman, and David A. Schwartz. Specificity and complexity of the caenorhabditis elegans innate immune response. Aug 2007. URL: https://doi.org/10.1128/mcb.02070-06, doi:10.1128/mcb.02070-06. This article has 232 citations and is from a domain leading peer-reviewed journal.
(alper2007specificityandcomplexity pages 4-5): Scott Alper, Sandra J. McBride, Brad Lackford, Jonathan H. Freedman, and David A. Schwartz. Specificity and complexity of the caenorhabditis elegans innate immune response. Aug 2007. URL: https://doi.org/10.1128/mcb.02070-06, doi:10.1128/mcb.02070-06. This article has 232 citations and is from a domain leading peer-reviewed journal.
(dinic2021probioticmediatedp38mapk pages 4-5): Miroslav Dinić, Stefan Jakovljević, Jelena Đokić, Nikola Popović, Dušan Radojević, Ivana Strahinić, and Nataša Golić. Probiotic-mediated p38 mapk immune signaling prolongs the survival of caenorhabditis elegans exposed to pathogenic bacteria. Scientific Reports, Oct 2021. URL: https://doi.org/10.1038/s41598-021-00698-5, doi:10.1038/s41598-021-00698-5. This article has 45 citations and is from a peer-reviewed journal.
(zheng2021thebziptranscription pages 6-8): Zhongfan Zheng, Yilixiati Aihemaiti, Junqiang Liu, Muhammad Irfan Afridi, Shengmei Yang, Xiumei Zhang, Yongfu Xu, Chunhong Chen, and Haijun Tu. The bzip transcription factor zip-11 is required for the innate immune regulation in caenorhabditis elegans. Frontiers in Immunology, Nov 2021. URL: https://doi.org/10.3389/fimmu.2021.744454, doi:10.3389/fimmu.2021.744454. This article has 8 citations and is from a peer-reviewed journal.
(liu2013componentsofthe pages 4-5): Jinghua Liu, Jeff Hafting, Alan T. Critchley, Arjun H. Banskota, and Balakrishnan Prithiviraj. Components of the cultivated red seaweed chondrus crispus enhance the immune response of caenorhabditis elegans to pseudomonas aeruginosa through the pmk-1 , daf-2/daf-16 , and skn-1 pathways. Applied and Environmental Microbiology, 79:7343-7350, Dec 2013. URL: https://doi.org/10.1128/aem.01927-13, doi:10.1128/aem.01927-13. This article has 85 citations and is from a peer-reviewed journal.
(liu2013componentsofthe pages 2-2): Jinghua Liu, Jeff Hafting, Alan T. Critchley, Arjun H. Banskota, and Balakrishnan Prithiviraj. Components of the cultivated red seaweed chondrus crispus enhance the immune response of caenorhabditis elegans to pseudomonas aeruginosa through the pmk-1 , daf-2/daf-16 , and skn-1 pathways. Applied and Environmental Microbiology, 79:7343-7350, Dec 2013. URL: https://doi.org/10.1128/aem.01927-13, doi:10.1128/aem.01927-13. This article has 85 citations and is from a peer-reviewed journal.
(jensen2010rnaiscreenof pages 2-3): Victor L. Jensen, Karina T. Simonsen, Yu-Hui Lee, Donha Park, and Donald L. Riddle. Rnai screen of daf-16/foxo target genes in c. elegans links pathogenesis and dauer formation. PLoS ONE, 5:e15902, Dec 2010. URL: https://doi.org/10.1371/journal.pone.0015902, doi:10.1371/journal.pone.0015902. This article has 37 citations and is from a peer-reviewed journal.
(jensen2010rnaiscreenof pages 4-5): Victor L. Jensen, Karina T. Simonsen, Yu-Hui Lee, Donha Park, and Donald L. Riddle. Rnai screen of daf-16/foxo target genes in c. elegans links pathogenesis and dauer formation. PLoS ONE, 5:e15902, Dec 2010. URL: https://doi.org/10.1371/journal.pone.0015902, doi:10.1371/journal.pone.0015902. This article has 37 citations and is from a peer-reviewed journal.
(mallo2002inducibleantibacterialdefense pages 1-2): Gustavo V. Mallo, C.Léopold Kurz, Carole Couillault, Nathalie Pujol, Samuel Granjeaud, Yuji Kohara, and Jonathan J. Ewbank. Inducible antibacterial defense system in c. elegans. Current Biology, 12:1209-1214, Jul 2002. URL: https://doi.org/10.1016/s0960-9822(02)00928-4, doi:10.1016/s0960-9822(02)00928-4. This article has 614 citations and is from a highest quality peer-reviewed journal.
(schulenburg2004evolutionofthe pages 6-7): Hinrich Schulenburg, C. Léopold Kurz, and Jonathan J. Ewbank. Evolution of the innate immune system: the worm perspective. Immunological Reviews, 198:36-58, Apr 2004. URL: https://doi.org/10.1111/j.0105-2896.2004.0125.x, doi:10.1111/j.0105-2896.2004.0125.x. This article has 317 citations and is from a domain leading peer-reviewed journal.
(jensen2010rnaiscreenof pages 3-4): Victor L. Jensen, Karina T. Simonsen, Yu-Hui Lee, Donha Park, and Donald L. Riddle. Rnai screen of daf-16/foxo target genes in c. elegans links pathogenesis and dauer formation. PLoS ONE, 5:e15902, Dec 2010. URL: https://doi.org/10.1371/journal.pone.0015902, doi:10.1371/journal.pone.0015902. This article has 37 citations and is from a peer-reviewed journal.
(alper2007specificityandcomplexity pages 1-2): Scott Alper, Sandra J. McBride, Brad Lackford, Jonathan H. Freedman, and David A. Schwartz. Specificity and complexity of the caenorhabditis elegans innate immune response. Aug 2007. URL: https://doi.org/10.1128/mcb.02070-06, doi:10.1128/mcb.02070-06. This article has 232 citations and is from a domain leading peer-reviewed journal.
(vollmer2008bacterialpeptidoglycan(murein) pages 6-7): Waldemar Vollmer, Bernard Joris, Paulette Charlier, and Simon Foster. Bacterial peptidoglycan (murein) hydrolases. FEMS microbiology reviews, 32 2:259-86, Mar 2008. URL: https://doi.org/10.1111/j.1574-6976.2007.00099.x, doi:10.1111/j.1574-6976.2007.00099.x. This article has 1226 citations and is from a domain leading peer-reviewed journal.